|
|
 |
|
| | |
| | | | | | | |
family
|
|
PR:000000018 |
latent TGF-beta-binding protein
|
IFNG
|
"A protein that is similar in overall domain structure to fibrillins that is mainly composed of two types of repeated protein domains, namely epidermal growth factor (EGF-like) and TB (8-Cys-like repeats). The latent TGF-beta-binding protein is characterized by having four of the TB domains." [PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
gene
|
|
PR:000000101 |
latent TGF-beta-binding protein 1
|
LTBP1
|
"A latent TGF-beta-binding protein that is a translation product of the human LTBP1 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
organism-gene
|
|
PR:Q00918 |
latent-transforming growth factor beta-binding protein 1 (rat)
|
rLTBP1
|
"A latent TGF-beta-binding protein 1 that is encoded in the genome of rat." [OMA:Q00918, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | |
organism-gene
|
|
PR:Q14766 |
latent-transforming growth factor beta-binding protein 1 (human)
|
hLTBP1
|
"A latent TGF-beta-binding protein 1 that is encoded in the genome of human." [PRO:CNA, UniProtKB:Q14766]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:Q14766-1 |
latent-transforming growth factor beta-binding protein 1 isoform Long (human)
|
hLTBP1/iso:Long
|
"A latent TGF-beta-binding protein 1 isoform 1 that is encoded in the genome of human." [PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036463 |
latent TGF-beta-binding protein 1 isoform 1, signal peptide removed form (human)
|
hLTBP1/iso:1/SigPep-
|
"A latent TGF-beta-binding protein 1 isoform 1, signal peptide removed form in human. UniProtKB:Q14766-1, 24-1721." [PMID:8537398, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:Q14766-2 |
latent-transforming growth factor beta-binding protein 1 isoform Short (human)
|
hLTBP1/iso:Short
|
"A latent TGF-beta-binding protein 1 isoform 2 that is encoded in the genome of human." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036461 |
latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form (human)
|
hLTBP1/iso:2/SigPep-
|
"A latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form in human. UniProtKB:Q14766-2, 21-1395." [PMID:10930463, PMID:11104663, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:Q14766-3 |
latent-transforming growth factor beta-binding protein 1 isoform h3 (human)
|
hLTBP1/iso:h3
|
"A latent-transforming growth factor beta-binding protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q14766-3." [PRO:DNx, UniProtKB:Q14766]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:Q14766-4 |
latent-transforming growth factor beta-binding protein 1 isoform h4 (human)
|
hLTBP1/iso:h4
|
"A latent-transforming growth factor beta-binding protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q14766-4." [PRO:DNx, UniProtKB:Q14766]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:Q14766-5 |
latent-transforming growth factor beta-binding protein 1 isoform h5 (human)
|
hLTBP1/iso:h5
|
"A latent-transforming growth factor beta-binding protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q14766-5." [PRO:DNx, UniProtKB:Q14766]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000048267 |
latent-transforming growth factor beta-binding protein 1, signal peptide removed form (human)
|
hLTBP1/SigPep-
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has had the signal peptide removed. UniProtKB:Q14766, 24-1721." [PRO:DNx, Reactome:R-HSA-2161391]
|
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036461 |
latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form (human)
|
hLTBP1/iso:2/SigPep-
|
"A latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form in human. UniProtKB:Q14766-2, 21-1395." [PMID:10930463, PMID:11104663, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036463 |
latent TGF-beta-binding protein 1 isoform 1, signal peptide removed form (human)
|
hLTBP1/iso:1/SigPep-
|
"A latent TGF-beta-binding protein 1 isoform 1, signal peptide removed form in human. UniProtKB:Q14766-1, 24-1721." [PMID:8537398, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000060399 |
latent-transforming growth factor beta-binding protein 1, signal peptide removed phosphorylated form (human)
|
hLTBP1/SigPep-/PhosRes+
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. Example: UniProtKB:Q14766-1, 24-1721, MOD:00696." [PRO:DNx, Reactome:R-HSA-8957050]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057228 |
latent-transforming growth factor beta-binding protein 1 N-glycosylated 1 (human)
|
hLTBP1/NGlyco:1
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-378 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G57776ZU. Example: UniProtKB:Q14766-1, Asn-378, MOD:00160~GNO:G57776ZU." [GlyGen:Q14766-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057229 |
latent-transforming growth factor beta-binding protein 1 N-glycosylated 2 (human)
|
hLTBP1/NGlyco:2
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-378 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:Q14766-1, Asn-378, MOD:00160~GNO:G10486CT." [GlyGen:Q14766-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057231 |
latent-transforming growth factor beta-binding protein 1 N-glycosylated 4 (human)
|
hLTBP1/NGlyco:4
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-378 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:Q14766-1, Asn-378, MOD:00160~GNO:G59626AS." [GlyGen:Q14766-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057232 |
latent-transforming growth factor beta-binding protein 1 N-glycosylated 5 (human)
|
hLTBP1/NGlyco:5
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-378 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G60033FS. Example: UniProtKB:Q14766-1, Asn-378, MOD:00160~GNO:G60033FS." [GlyGen:Q14766-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057233 |
latent-transforming growth factor beta-binding protein 1 N-glycosylated 6 (human)
|
hLTBP1/NGlyco:6
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-378 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G72790NZ. Example: UniProtKB:Q14766-1, Asn-378, MOD:00160~GNO:G72790NZ." [GlyGen:Q14766-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057235 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 1 (human)
|
hLTBP1/OGlyco:1
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Ser-278 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14766-1, Ser-278, MOD:00002~GNO:G43417UB." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057236 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 2 (human)
|
hLTBP1/OGlyco:2
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Ser-846 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14766-1, Ser-846, MOD:00002~GNO:G43417UB." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057237 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 3 (human)
|
hLTBP1/OGlyco:3
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-1601 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14766-1, Thr-1601, MOD:00005~GNO:G43417UB." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057238 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 4 (human)
|
hLTBP1/OGlyco:4
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-290 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14766-1, Thr-290, MOD:00005~GNO:G43417UB." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057239 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 5 (human)
|
hLTBP1/OGlyco:5
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-461 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14766-1, Thr-461, MOD:00005~GNO:G43417UB." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057240 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 6 (human)
|
hLTBP1/OGlyco:6
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-661 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14766-1, Thr-661, MOD:00005~GNO:G43417UB." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057241 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 7 (human)
|
hLTBP1/OGlyco:7
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-769 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14766-1, Thr-769, MOD:00005~GNO:G29068FM." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057242 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 8 (human)
|
hLTBP1/OGlyco:8
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-769 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14766-1, Thr-769, MOD:00005~GNO:G43417UB." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057243 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 9 (human)
|
hLTBP1/OGlyco:9
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-801 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14766-1, Thr-801, MOD:00005~GNO:G43417UB." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057244 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 10 (human)
|
hLTBP1/OGlyco:10
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-831 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14766-1, Thr-831, MOD:00005~GNO:G43417UB." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057245 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 11 (human)
|
hLTBP1/OGlyco:11
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-845 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q14766-1, Thr-845, MOD:00005~GNO:G53434XO." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057246 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 12 (human)
|
hLTBP1/OGlyco:12
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-845 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:Q14766-1, Thr-845, MOD:00005~GNO:G58001LT." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057247 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 13 (human)
|
hLTBP1/OGlyco:13
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-869 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14766-1, Thr-869, MOD:00005~GNO:G29068FM." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057248 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 14 (human)
|
hLTBP1/OGlyco:14
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-869 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14766-1, Thr-869, MOD:00005~GNO:G43417UB." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057249 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 15 (human)
|
hLTBP1/OGlyco:15
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-869 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q14766-1, Thr-869, MOD:00005~GNO:G53434XO." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057250 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 16 (human)
|
hLTBP1/OGlyco:16
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-869 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G57317CE. Example: UniProtKB:Q14766-1, Thr-869, MOD:00005~GNO:G57317CE." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057251 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 17 (human)
|
hLTBP1/OGlyco:17
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-869 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:Q14766-1, Thr-869, MOD:00005~GNO:G58001LT." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057252 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 18 (human)
|
hLTBP1/OGlyco:18
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-872 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14766-1, Thr-872, MOD:00005~GNO:G43417UB." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057253 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 19 (human)
|
hLTBP1/OGlyco:19
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-878 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14766-1, Thr-878, MOD:00005~GNO:G43417UB." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057254 |
latent-transforming growth factor beta-binding protein 1 O-glycosylated 20 (human)
|
hLTBP1/OGlyco:20
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been O-glycosylated at the residue equivalent to Thr-920 of the amino acid sequence represented by UniProtKB:Q14766-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14766-1, Thr-920, MOD:00005~GNO:G43417UB." [GlyGen:Q14766-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000060399 |
latent-transforming growth factor beta-binding protein 1, signal peptide removed phosphorylated form (human)
|
hLTBP1/SigPep-/PhosRes+
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. Example: UniProtKB:Q14766-1, 24-1721, MOD:00696." [PRO:DNx, Reactome:R-HSA-8957050]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000066752 |
latent-transforming growth factor beta-binding protein 1 cysteinylated 1 (human)
|
hLTBP1/Cyst:1
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-403 of the amino acid sequence represented by UniProtKB:Q14766-1. Example: UniProtKB:Q14766-1, Cys-403, MOD:00765." [IEDB_epitope:2116664, IEDB_epitope:2116665, IEDB_epitope:2118901, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000079465 |
latent-transforming growth factor beta-binding protein 1 cysteinylated 2 (human)
|
hLTBP1/Cyst:2
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-559 of the amino acid sequence represented by UniProtKB:Q14766-1. Example: UniProtKB:Q14766-1, Cys-559, MOD:00765." [IEDB_epitope:2116519, IEDB_epitope:2123522, IEDB_epitope:2129056, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000079568 |
latent-transforming growth factor beta-binding protein 1 cysteinylated 3 (human)
|
hLTBP1/Cyst:3
|
"A latent-transforming growth factor beta-binding protein 1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-361 of the amino acid sequence represented by UniProtKB:Q14766-1. Example: UniProtKB:Q14766-1, Cys-361, MOD:00765." [IEDB_epitope:2121249, IEDB_epitope:2121250, IEDB_epitope:2121251, IEDB_epitope:2121252, IEDB_epitope:2128727, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | |
organism-gene
|
|
PR:Q8CG19 |
latent-transforming growth factor beta-binding protein 1 (mouse)
|
mLTBP1
|
"A latent TGF-beta-binding protein 1 that is encoded in the genome of mouse." [OMA:Q8CG19, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:Q8CG19-1 |
latent-transforming growth factor beta-binding protein 1 isoform Long (mouse)
|
mLTBP1/iso:Long
|
"A latent TGF-beta-binding protein 1 isoform 1 that is encoded in the genome of mouse." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:Q8CG19-2 |
latent-transforming growth factor beta-binding protein 1 isoform Short (mouse)
|
mLTBP1/iso:Short
|
"A latent TGF-beta-binding protein 1 isoform 2 that is encoded in the genome of mouse." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036462 |
latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form (mouse)
|
mLTBP1/iso:2/SigPep-
|
"A latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form in mouse. UniProtKB:Q8CG19-2, 20-1394." [PMID:11104663, PMID:7730318, PMID:9008713, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:Q8CG19-3 |
latent-transforming growth factor beta-binding protein 1 isoform m3 (mouse)
|
mLTBP1/iso:m3
|
"A latent-transforming growth factor beta-binding protein 1 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8CG19-3." [PRO:DNx, UniProtKB:Q8CG19]
|
|
|
|
|
|
|
| | | | | | |
| | | |
sequence
|
|
PR:000000285 |
latent TGF-beta-binding protein 1 isoform 1
|
LTBP1/iso:1
|
"A latent TGF-beta-binding protein 1 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q14766-1 or a 1:1 ortholog thereof." [PMID:8537398, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:Q14766-1 |
latent-transforming growth factor beta-binding protein 1 isoform Long (human)
|
hLTBP1/iso:Long
|
"A latent TGF-beta-binding protein 1 isoform 1 that is encoded in the genome of human." [PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036463 |
latent TGF-beta-binding protein 1 isoform 1, signal peptide removed form (human)
|
hLTBP1/iso:1/SigPep-
|
"A latent TGF-beta-binding protein 1 isoform 1, signal peptide removed form in human. UniProtKB:Q14766-1, 24-1721." [PMID:8537398, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:Q8CG19-1 |
latent-transforming growth factor beta-binding protein 1 isoform Long (mouse)
|
mLTBP1/iso:Long
|
"A latent TGF-beta-binding protein 1 isoform 1 that is encoded in the genome of mouse." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| |
modification
|
|
PR:000000553 |
latent TGF-beta-binding protein 1 isoform 1, signal peptide removed form
|
LTBP1/iso:1/SigPep-
|
"A latent TGF-beta-binding protein 1 isoform 1 that has had the signal peptide removed. This form binds covalently to the latent associated peptide of the transforming growth factors through the third TB domain by disulfide bridging." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036463 |
latent TGF-beta-binding protein 1 isoform 1, signal peptide removed form (human)
|
hLTBP1/iso:1/SigPep-
|
"A latent TGF-beta-binding protein 1 isoform 1, signal peptide removed form in human. UniProtKB:Q14766-1, 24-1721." [PMID:8537398, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | |
sequence
|
|
PR:000000286 |
latent TGF-beta-binding protein 1 isoform 2
|
LTBP1/iso:2
|
"A latent TGF-beta-binding protein 1 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q14766-2 or a 1:1 ortholog thereof." [PMID:8537398, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:Q14766-2 |
latent-transforming growth factor beta-binding protein 1 isoform Short (human)
|
hLTBP1/iso:Short
|
"A latent TGF-beta-binding protein 1 isoform 2 that is encoded in the genome of human." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036461 |
latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form (human)
|
hLTBP1/iso:2/SigPep-
|
"A latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form in human. UniProtKB:Q14766-2, 21-1395." [PMID:10930463, PMID:11104663, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:Q8CG19-2 |
latent-transforming growth factor beta-binding protein 1 isoform Short (mouse)
|
mLTBP1/iso:Short
|
"A latent TGF-beta-binding protein 1 isoform 2 that is encoded in the genome of mouse." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036462 |
latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form (mouse)
|
mLTBP1/iso:2/SigPep-
|
"A latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form in mouse. UniProtKB:Q8CG19-2, 20-1394." [PMID:11104663, PMID:7730318, PMID:9008713, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
modification
|
|
PR:000000552 |
latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form
|
LTBP1/iso:2/SigPep-
|
"A latent TGF-beta-binding protein 1 isoform 2 that has had the signal peptide removed. This form binds covalently to the latent associated peptide of the transforming growth factors through the third TB domain by disulfide bridging." [PMID:14607119, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036461 |
latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form (human)
|
hLTBP1/iso:2/SigPep-
|
"A latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form in human. UniProtKB:Q14766-2, 21-1395." [PMID:10930463, PMID:11104663, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036462 |
latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form (mouse)
|
mLTBP1/iso:2/SigPep-
|
"A latent TGF-beta-binding protein 1 isoform 2, signal peptide removed form in mouse. UniProtKB:Q8CG19-2, 20-1394." [PMID:11104663, PMID:7730318, PMID:9008713, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000025430 |
latent TGF-beta-binding protein 1 proteolytic cleavage product
|
LTBP1/ClvPrd
|
"A latent TGF-beta-binding protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | |
gene
|
|
PR:000009973 |
latent-transforming growth factor beta-binding protein 2
|
LTBP2
|
"A latent TGF-beta-binding protein that is a translation product of the human LTBP2 gene or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | |
organism-gene
|
|
PR:O08999 |
latent-transforming growth factor beta-binding protein 2 (mouse)
|
mLTBP2
|
"A latent-transforming growth factor beta-binding protein 2 that is encoded in the genome of mouse." [OMA:O08999, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | |
organism-gene
|
|
PR:O35806 |
latent-transforming growth factor beta-binding protein 2 (rat)
|
rLTBP2
|
"A latent-transforming growth factor beta-binding protein 2 that is encoded in the genome of rat." [OMA:O35806, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | |
organism-gene
|
|
PR:Q14767 |
latent-transforming growth factor beta-binding protein 2 (human)
|
hLTBP2
|
"A latent-transforming growth factor beta-binding protein 2 that is encoded in the genome of human." [PRO:DNx, UniProtKB:Q14767]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000048268 |
latent-transforming growth factor beta-binding protein 2, signal peptide removed form (human)
|
hLTBP2/SigPep-
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has had the signal peptide removed. UniProtKB:Q14767, 36-1821." [PRO:DNx, Reactome:R-HSA-2161340]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057255 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 1 (human)
|
hLTBP2/OGlyco:1
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Ser-267 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Ser-267, MOD:00002~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057256 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 2 (human)
|
hLTBP2/OGlyco:2
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Ser-273 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Ser-273, MOD:00002~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057257 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 3 (human)
|
hLTBP2/OGlyco:3
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Ser-288 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14767-1, Ser-288, MOD:00002~GNO:G29068FM." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057258 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 4 (human)
|
hLTBP2/OGlyco:4
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Ser-288 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Ser-288, MOD:00002~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057259 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 5 (human)
|
hLTBP2/OGlyco:5
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Ser-308 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Ser-308, MOD:00002~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057260 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 6 (human)
|
hLTBP2/OGlyco:6
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Ser-311 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14767-1, Ser-311, MOD:00002~GNO:G29068FM." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057261 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 7 (human)
|
hLTBP2/OGlyco:7
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Ser-311 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Ser-311, MOD:00002~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057262 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 8 (human)
|
hLTBP2/OGlyco:8
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Ser-311 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q14767-1, Ser-311, MOD:00002~GNO:G53434XO." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057263 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 9 (human)
|
hLTBP2/OGlyco:9
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Ser-312 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14767-1, Ser-312, MOD:00002~GNO:G29068FM." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057264 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 10 (human)
|
hLTBP2/OGlyco:10
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Ser-312 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Ser-312, MOD:00002~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057265 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 11 (human)
|
hLTBP2/OGlyco:11
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Ser-468 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Ser-468, MOD:00002~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057266 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 12 (human)
|
hLTBP2/OGlyco:12
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Ser-518 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Ser-518, MOD:00002~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057267 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 13 (human)
|
hLTBP2/OGlyco:13
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-1401 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14767-1, Thr-1401, MOD:00005~GNO:G29068FM." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057268 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 14 (human)
|
hLTBP2/OGlyco:14
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-278 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14767-1, Thr-278, MOD:00005~GNO:G29068FM." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057269 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 15 (human)
|
hLTBP2/OGlyco:15
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-278 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Thr-278, MOD:00005~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057270 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 16 (human)
|
hLTBP2/OGlyco:16
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-278 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G88713AC. Example: UniProtKB:Q14767-1, Thr-278, MOD:00005~GNO:G88713AC." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057271 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 17 (human)
|
hLTBP2/OGlyco:17
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-285 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14767-1, Thr-285, MOD:00005~GNO:G29068FM." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057272 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 18 (human)
|
hLTBP2/OGlyco:18
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-285 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Thr-285, MOD:00005~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057273 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 19 (human)
|
hLTBP2/OGlyco:19
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-303 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G29063QY. Example: UniProtKB:Q14767-1, Thr-303, MOD:00005~GNO:G29063QY." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057274 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 20 (human)
|
hLTBP2/OGlyco:20
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-303 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Thr-303, MOD:00005~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057275 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 21 (human)
|
hLTBP2/OGlyco:21
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-303 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G57317CE. Example: UniProtKB:Q14767-1, Thr-303, MOD:00005~GNO:G57317CE." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057276 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 22 (human)
|
hLTBP2/OGlyco:22
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-305 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Thr-305, MOD:00005~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057277 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 23 (human)
|
hLTBP2/OGlyco:23
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-380 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Thr-380, MOD:00005~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057278 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 24 (human)
|
hLTBP2/OGlyco:24
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-509 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14767-1, Thr-509, MOD:00005~GNO:G29068FM." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057279 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 25 (human)
|
hLTBP2/OGlyco:25
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-509 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Thr-509, MOD:00005~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057280 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 26 (human)
|
hLTBP2/OGlyco:26
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-802 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Thr-802, MOD:00005~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057281 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 27 (human)
|
hLTBP2/OGlyco:27
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-813 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Thr-813, MOD:00005~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057282 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 28 (human)
|
hLTBP2/OGlyco:28
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-813 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q14767-1, Thr-813, MOD:00005~GNO:G53434XO." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057283 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 29 (human)
|
hLTBP2/OGlyco:29
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-831 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q14767-1, Thr-831, MOD:00005~GNO:G53434XO." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057284 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 30 (human)
|
hLTBP2/OGlyco:30
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-831 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G57317CE. Example: UniProtKB:Q14767-1, Thr-831, MOD:00005~GNO:G57317CE." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057285 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 31 (human)
|
hLTBP2/OGlyco:31
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-839 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14767-1, Thr-839, MOD:00005~GNO:G29068FM." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000057286 |
latent-transforming growth factor beta-binding protein 2 O-glycosylated 32 (human)
|
hLTBP2/OGlyco:32
|
"A latent-transforming growth factor beta-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-839 of the amino acid sequence represented by UniProtKB:Q14767-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14767-1, Thr-839, MOD:00005~GNO:G43417UB." [GlyGen:Q14767-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
